Overview
Telehealth services have become a key strategy for expanding access to care during the COVID-19 pandemic, driven in part by significant changes in laws and regulations to encourage the adoption of technologies that support telehealth. With these rapid changes, providers are struggling to understand how to best serve their patients using telehealth technologies.
During this webinar, HMA experts will describe the different modalities of telehealth and will lay out the policy and reimbursement implications for the Medicare and Medicaid programs. Detail changes to HIPAA enforcement and policy changes that ensure ongoing support for prescribers and recipients of controlled substances will be discussed. This webinar will also review how recent policy changes impact key provider decisions with regards to selecting, implementing, and building a business case for new telehealth services to support patients during the pandemic.
Learning Objectives
- Understand the different modalities of telehealth services and how to bill for them
- Find out about recent changes in Medicare and Medicaid reimbursement policy stemming from the COVID-19 response
- Learn the key steps in selecting a telehealth platform, building a business case, adapting workflows, and other implications for physician practices
Moderator
Kate Slatt, Vice President, Innovative Payment and Care Delivery, HAP
Speakers
Jean Glossa, MD, Managing Principal for Clinical Services, HMA
David Bergman, MPA, Principal, HMA
Zach Gaumer, Senior Consultant, Washington, HMA
This webinar is comlimentary for HAP members. Registration is required.